YahooJuly 31, 2026 at 3:31 PM NYlast month

Johnson & Johnson vs. Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?

Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 ⁠billion, above analysts’ average estimate of about $25.05 billion. Adjusted earnings per share reached $2.90, surpassing the expectation of $2.85. The company also raised its guidance and stated that it is on track to meet […]

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo

Read at Source

Companies in This Story

JNJJohnson & Johnson275.53− 1.04%

Companies in This Story

Related Stories